WHO list of prequalified in vitro diagnostic products updated
The WHO list of prequalified in vitro diagnostic products has been updated.
The WHO list of prequalified in vitro diagnostic products has been updated.
Molnupiravir 200 mg capsules for oral administration invited for COVID-19.
The WHO list of prequalified in vitro diagnostic products has been updated.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
A nitrosamine impurity, 1-methyl-4-nitrosopiperazine (MeNP), was identified in rifampicin products.
A 1st Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit is being published by
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
The WHO list of prequalified in vitro diagnostic products has been updated.
Casirivimab and imdevimab combination invited for COVID-19.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO bioequivalence guidelines (TRS No.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: